Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 1863 entries
View as:

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00853697 Org: User:
Start: 03/31/09 End: 11/30/12 Due: 11/30/13

Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01186705 Org: User:
Start: 08/31/10 End: 08/31/11 Due: 08/31/12

BMS-247550 in Treating Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00020904 Org: User:
Start: 02/28/01 End: 01/31/03 Due: 01/31/04

A Study of Mosunetuzumab in People With Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05389293 Org: User:
Start: 05/27/22 End: 12/31/26 Due: 12/31/27

Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission

Phase: N/A Priority: Normal
NCT ID: NCT00002609 Org: User:
Start: 08/31/94 End: 02/28/03 Due: 02/28/04

Yoga Practice for Breast or Ovarian Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02305498 Org: User:
Start: 11/24/14 End: 03/11/19 Due: 03/11/20

Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00354679 Org: User:
Start: 04/30/06 End: 06/30/15 Due: 06/30/16

Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02525653 Org: User:
Start: 08/31/15 End: 05/31/19 Due: 05/31/20

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003394 Org: User:
Start: 04/30/98 End: 04/30/03 Due: 04/30/04

A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04416451 Org: User:
Start: 05/04/21 End: 06/30/25 Due: 06/30/26

Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01543659 Org: User:
Start: 02/21/12 End: 02/21/26 Due: 02/21/27

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06863233 Org: User:
Start: 03/03/25 End: 03/03/28 Due: 03/03/29

Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)

Phase: N/A Priority: Normal
NCT ID: NCT02571673 Org: User:
Start: 10/05/15 End: 02/15/23 Due: 02/15/24

Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases

Phase: N/A Priority: Normal
NCT ID: NCT02320825 Org: User:
Start: 12/16/14 End: 07/26/18 Due: 07/26/19

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01920737 Org: User:
Start: 08/31/13 End: 08/31/25 Due: 08/31/26

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02494869 Org: User:
Start: 07/31/15 End: 07/31/25 Due: 07/31/26

Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype

Phase: N/A Priority: Normal
NCT ID: NCT02658279 Org: User:
Start: 01/22/16 End: 01/31/26 Due: 01/31/27

Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and Anxiety

Phase: N/A Priority: Normal
NCT ID: NCT00712569 Org: User:
Start: 06/30/08 End: 02/28/15 Due: 02/28/16

Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in Children

Phase: N/A Priority: Normal
NCT ID: NCT03866460 Org: User:
Start: 03/06/19 End: 11/04/24 Due: 11/04/25

Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00005631 Org: User:
Start: 11/30/99 End: 11/30/02 Due: 11/30/03

Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum

Phase: N/A Priority: Normal
NCT ID: NCT00012090 Org: User:
Start: 09/30/00 End: 04/30/04 Due: 04/30/05

Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003443 Org: User:
Start: 07/31/98 End: 05/31/01 Due: 05/31/02

Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection

Phase: N/A Priority: Normal
NCT ID: NCT00588341 Org: User:
Start: 09/30/05 End: 03/31/09 Due: 03/31/10

Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00590109 Org: User:
Start: 03/31/97 End: 12/22/21 Due: 12/22/22

Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device

Phase: N/A Priority: Normal
NCT ID: NCT00607529 Org: User:
Start: 08/31/07 End: 05/31/10 Due: 05/31/11